Sign up
Pharma Capital

Arev Brands International appoints new CEO

Arev Brands International announced the appointment of Mike Withrow as the company's chief executive officer
1539296511_arev.jpg
Last month, Arev announced that it had discovered a new extraction approach in the drinks and cannabis space

Ingredients and extraction firm Arev Brands International Ltd (CSE:AREV) announced Thursday that it has appointed Mike Withrow as the company's chief executive officer, effective Oct. 11, 2018.

The company said Stephane Maher has stepped down as CEO to focus his efforts on being the Business Development Manager, Quebec.

Maher will be executing the company's tactical direction in Quebec, and review strategic opportunities presented to the company within this territory and the surrounding areas.

READ: Arev Brands International hails terpene infusion discovery, which could be a game-changer

"It is great to have Mr. Withrow come on in the capacity of CEO to see the company through to the next phase. We have been so fortunate to not only have his skills and expertise to guide us, but Mr. Withrow has also agreed to work for $1 a year, until such time as the company is revenue positive," said Scott Davis, Arev CFO. 

Last month, Arev announced that it reached a major milestone - discovering an extraction approach which could be a game-changer in the drinks and cannabis space.

Shares of Arev Brands International were $0.38 on Thursday.



Register here to be notified of future Company articles
View full profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.